{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:15:01Z","timestamp":1790021701990,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02425-0","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T08:04:12Z","timestamp":1667289852000},"page":"799-806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["An analysis of lactate dehydrogenase (LDH) levels in advanced stage IV melanoma of the skin: prognostic capabilities and demographic variability"],"prefix":"10.1007","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6873-3217","authenticated-orcid":false,"given":"Amar D.","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree","family":"Chinta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vraj P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Paskhover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3036-3825","authenticated-orcid":false,"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"issue":"10","key":"2425_CR1","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/imj.13574","volume":"47","author":"V Atkinson","year":"2017","unstructured":"Atkinson V (2017) Recent advances in malignant melanoma. Intern Med J 47(10):1114\u20131121. https:\/\/doi.org\/10.1111\/imj.13574","journal-title":"Intern Med J"},{"key":"2425_CR2","unstructured":"Five-Year Survival Rates | SEER Training. https:\/\/training.seer.cancer.gov\/melanoma\/intro\/survival.html. Accessed 13 July 2021"},{"issue":"5","key":"2425_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.amepre.2012.07.031","volume":"43","author":"GP Guy","year":"2012","unstructured":"Guy GP, Ekwueme DU, Tangka FK, Richardson LC (2012) Melanoma treatment costs. Am J Prev Med 43(5):537\u2013545. https:\/\/doi.org\/10.1016\/j.amepre.2012.07.031","journal-title":"Am J Prev Med"},{"issue":"3","key":"2425_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/archdermatol.2009.389","volume":"146","author":"AM Seidler","year":"2010","unstructured":"Seidler AM, Pennie ML, Veledar E, Culler SD, Chen SC (2010) Economic burden of melanoma in the elderly population: population-based analysis of the surveillance, epidemiology, and end results (SEER)\u2013Medicare Data. Arch Dermatol 146(3):249\u2013256. https:\/\/doi.org\/10.1001\/archdermatol.2009.389","journal-title":"Arch Dermatol"},{"issue":"9","key":"2425_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/archsurg.139.9.961","volume":"139","author":"R Essner","year":"2004","unstructured":"Essner R, Lee JH, Wanek LA, Itakura H, Morton DL (2004) Contemporary surgical treatment of advanced-stage melanoma. Arch Surg Chic Ill 1960. 139(9):961\u2013966. https:\/\/doi.org\/10.1001\/archsurg.139.9.961 (discussion 966-967)","journal-title":"Arch Surg Chic Ill 1960."},{"issue":"36","key":"2425_CR6","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, jaw SS et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27(36):6199\u20136206. https:\/\/doi.org\/10.1200\/JCO.2009.23.4799","journal-title":"J Clin Oncol"},{"issue":"5","key":"2425_CR7","first-page":"1799","volume":"30","author":"F Egberts","year":"2010","unstructured":"Egberts F, Momkvist A, Egberts JH, Kaehler KC, Hauschild A (2010) Serum S100B and LDH are not useful in predicting the sentinel node status in melanoma patients. Anticancer Res 30(5):1799\u20131805","journal-title":"Anticancer Res"},{"key":"2425_CR8","doi-asserted-by":"crossref","unstructured":"Belter B, Haase-Kohn C, Pietzsch J (2017) Biomarkers in malignant melanoma: recent trends and critical perspective. In: Ward WH, Farma JM (eds) Cutaneous melanoma: etiology and therapy. Codon Publications. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK481856\/. Accessed 25 July 2022","DOI":"10.15586\/codon.cutaneousmelanoma.2017.ch3"},{"issue":"7","key":"2425_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3109\/0284186X.2015.1043026","volume":"54","author":"F Petrelli","year":"2015","unstructured":"Petrelli F, Cabiddu M, Coinu A et al (2015) Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies. Acta Oncol 54(7):961\u2013970. https:\/\/doi.org\/10.3109\/0284186X.2015.1043026","journal-title":"Acta Oncol"},{"issue":"7","key":"2425_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ebiom.2015.05.011","volume":"2","author":"MS Stark","year":"2015","unstructured":"Stark MS, Klein K, Weide B et al (2015) The prognostic and predictive value of melanoma-related MicroRNAs using tissue and serum: a MicroRNA Expression Analysis. EBioMedicine 2(7):671\u2013680. https:\/\/doi.org\/10.1016\/j.ebiom.2015.05.011","journal-title":"EBioMedicine"},{"issue":"22","key":"2425_CR11","doi-asserted-by":"publisher","first-page":"8650","DOI":"10.1002\/cam4.3474","volume":"9","author":"GM Fischer","year":"2020","unstructured":"Fischer GM, Carapeto FCL, Joon AY et al (2020) Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker. Cancer Med 9(22):8650\u20138661. https:\/\/doi.org\/10.1002\/cam4.3474","journal-title":"Cancer Med"},{"issue":"14","key":"2425_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025318","volume":"100","author":"J Xu","year":"2021","unstructured":"Xu J, Zhao J, Wang J, Sun C, Zhu X (2021) Prognostic value of lactate dehydrogenase for melanoma patients receiving anti-PD-1\/PD-L1 therapy. Medicine (Baltimore) 100(14):e25318. https:\/\/doi.org\/10.1097\/MD.0000000000025318","journal-title":"Medicine (Baltimore)"},{"key":"2425_CR13","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654","author":"Cancer Statistics","year":"2021","unstructured":"Cancer Statistics (2021) Siegel. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21654 (Accessed September 20, 2021)","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2425_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<589::AID-CNCR15>3.0.CO;2-I","volume":"88","author":"AA Marghoob","year":"2000","unstructured":"Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS (2000) Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging. Cancer 88(3):589\u2013595","journal-title":"Cancer"},{"issue":"3","key":"2425_CR15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1046\/j.1365-2133.2001.04071.x","volume":"144","author":"JE Osborne","year":"2001","unstructured":"Osborne JE, Hutchinson PE (2001) Clinical correlates of Breslow thickness of malignant melanoma. Br J Dermatol 144(3):476\u2013483. https:\/\/doi.org\/10.1046\/j.1365-2133.2001.04071.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"2425_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaad.2018.03.021","volume":"79","author":"JF Scott","year":"2018","unstructured":"Scott JF, Conic RZ, Thompson CL, Gerstenblith MR, Bordeaux JS (2018) Stage IV melanoma of unknown primary: a population-based study in the United States from 1973 to 2014. J Am Acad Dermatol 79(2):258-265.e4. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.021","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"2425_CR17","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1002\/cncr.24966","volume":"116","author":"Y Xing","year":"2010","unstructured":"Xing Y, Chang GJ, Hu CY et al (2010) Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer 116(9):2234\u20132241. https:\/\/doi.org\/10.1002\/cncr.24966","journal-title":"Cancer"},{"issue":"5","key":"2425_CR18","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.jaad.2016.06.006","volume":"75","author":"SM Dawes","year":"2016","unstructured":"Dawes SM, Tsai S, Gittleman H, Barnholtz-Sloan JS, Bordeaux JS (2016) Racial disparities in melanoma survival. J Am Acad Dermatol 75(5):983\u2013991. https:\/\/doi.org\/10.1016\/j.jaad.2016.06.006","journal-title":"J Am Acad Dermatol"},{"issue":"17","key":"2425_CR19","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1001\/archinte.166.17.1907","volume":"166","author":"JN Cormier","year":"2006","unstructured":"Cormier JN, Xing Y, Ding M et al (2006) Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 166(17):1907. https:\/\/doi.org\/10.1001\/archinte.166.17.1907","journal-title":"Arch Intern Med"},{"issue":"4","key":"2425_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4103\/0378-6323.136976","volume":"80","author":"G Kaminska-Winciorek","year":"2014","unstructured":"Kaminska-Winciorek G, Calik J, Wydmanski J, Schwartz RA, Czajkowski R (2014) Primary melanoma in rare locations: clinical and dermatoscopic features. Indian J Dermatol Venereol Leprol 80(4):369\u2013371. https:\/\/doi.org\/10.4103\/0378-6323.136976","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"2425_CR21","first-page":"236","volume":"16","author":"GA Patel","year":"2008","unstructured":"Patel GA, Ragi G, Krysicki J, Schwartz RA (2008) Subungual melanoma: a deceptive disorder. Acta Dermatovenerol Croat ADC 16(4):236\u2013242","journal-title":"Acta Dermatovenerol Croat ADC"},{"issue":"1","key":"2425_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12885-016-2747-6","volume":"16","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao Y, Ma S (2016) Racial differences in six major subtypes of melanoma: descriptive epidemiology. BMC Cancer 16(1):691. https:\/\/doi.org\/10.1186\/s12885-016-2747-6","journal-title":"BMC Cancer"},{"issue":"4","key":"2425_CR23","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.12788\/cutis.0235","volume":"107","author":"ML Elias","year":"2021","unstructured":"Elias ML, John AM, Maddukuri S, Schwartz RA, Lambert WC (2021) Treatment delay in melanoma: a risk factor analysis of an impending crisis. Cutis 107(4):E19\u2013E26. https:\/\/doi.org\/10.12788\/cutis.0235","journal-title":"Cutis"},{"issue":"10","key":"2425_CR24","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1245\/s10434-011-1706-3","volume":"18","author":"KK Collins","year":"2011","unstructured":"Collins KK, Fields RC, Baptiste D, Liu Y, Moley J, Jeffe DB (2011) Racial differences in survival after surgical treatment for melanoma. Ann Surg Oncol 18(10):2925\u20132936. https:\/\/doi.org\/10.1245\/s10434-011-1706-3","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2425_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/1354750X.2015.1118532","volume":"21","author":"GG Mokwatsi","year":"2016","unstructured":"Mokwatsi GG, Schutte AE, Kruger R (2016) A biomarker of tissue damage, lactate dehydrogenase, is associated with fibulin-1 and oxidative stress in blacks: the SAfrEIC study. Biomarkers 21(1):48\u201355. https:\/\/doi.org\/10.3109\/1354750X.2015.1118532","journal-title":"Biomarkers"},{"issue":"3","key":"2425_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/107327480801500308","volume":"15","author":"P Rouhani","year":"2008","unstructured":"Rouhani P, Hu S, Kirsner RS (2008) Melanoma in hispanic and black Americans. Cancer Control J Moffitt Cancer Cent 15(3):248\u2013253. https:\/\/doi.org\/10.1177\/107327480801500308","journal-title":"Cancer Control J Moffitt Cancer Cent"},{"issue":"1","key":"2425_CR27","first-page":"10","volume":"6","author":"K Byrd-Miles","year":"2007","unstructured":"Byrd-Miles K, Toombs EL, Peck GL (2007) Skin cancer in individuals of African, Asian, Latin-American, and American-Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians. J Drugs Dermatol JDD 6(1):10\u201316","journal-title":"J Drugs Dermatol JDD"},{"key":"2425_CR28","doi-asserted-by":"publisher","DOI":"10.5888\/pcd16.180640","author":"MB Culp","year":"2019","unstructured":"Culp MB (2019) 29 Melanoma among non-hispanic black Americans. Prev Chronic Dis. https:\/\/doi.org\/10.5888\/pcd16.180640","journal-title":"Prev Chronic Dis"},{"issue":"9","key":"2425_CR29","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1111\/jdv.15667","volume":"33","author":"ML Elias","year":"2019","unstructured":"Elias ML, Behbahani S, Maddukuri S, John AM, Schwartz RA, Lambert WC (2019) Prolonged overall survival following metastasectomy in stage IV melanoma. J Eur Acad Dermatol Venereol JEADV 33(9):1719\u20131725. https:\/\/doi.org\/10.1111\/jdv.15667","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"17","key":"2425_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003315","volume":"95","author":"M Ward-Peterson","year":"2016","unstructured":"Ward-Peterson M, Acu\u00f1a JM, Alkhalifah MK et al (2016) Association between race\/ethnicity and survival of melanoma patients in the united states over 3 decades. Medicine (Baltimore) 95(17):e3315. https:\/\/doi.org\/10.1097\/MD.0000000000003315","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"2425_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/archdermatol.2011.3227","volume":"148","author":"ZM Myles","year":"2012","unstructured":"Myles ZM, Buchanan N, King JB et al (2012) Anatomic distribution of malignant melanoma on the non-Hispanic black patient, 1998\u20132007. Arch Dermatol 148(7):797\u2013801. https:\/\/doi.org\/10.1001\/archdermatol.2011.3227","journal-title":"Arch Dermatol"},{"issue":"1","key":"2425_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1200\/JCO.2007.12.3604","volume":"26","author":"JA Zell","year":"2008","unstructured":"Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL, Anton-Culver H (2008) Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol Off J Am Soc Clin Oncol 26(1):66\u201375. https:\/\/doi.org\/10.1200\/JCO.2007.12.3604","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"2425_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.amepre.2008.03.026","volume":"35","author":"RA Pollitt","year":"2008","unstructured":"Pollitt RA, Clarke CA, Shema SJ, Swetter SM (2008) California medicaid enrollment and melanoma stage at diagnosis. Am J Prev Med 35(1):7\u201313. https:\/\/doi.org\/10.1016\/j.amepre.2008.03.026","journal-title":"Am J Prev Med"},{"issue":"3","key":"2425_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1470-2045(08)70032-9","volume":"9","author":"MT Halpern","year":"2008","unstructured":"Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY (2008) Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 9(3):222\u2013231. https:\/\/doi.org\/10.1016\/S1470-2045(08)70032-9","journal-title":"Lancet Oncol"},{"issue":"1","key":"2425_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CMR.0000000000000520","volume":"29","author":"F Petrelli","year":"2019","unstructured":"Petrelli F, Ardito R, Merelli B et al (2019) Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis. Melanoma Res 29(1):1\u201312. https:\/\/doi.org\/10.1097\/CMR.0000000000000520","journal-title":"Melanoma Res"},{"issue":"11","key":"2425_CR36","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.ejso.2020.07.011","volume":"46","author":"EA Deckers","year":"2020","unstructured":"Deckers EA, Kruijff S, Brouwers AH et al (2020) The association between active tumor volume, total lesion glycolysis and levels of S-100B and LDH in stage IV melanoma patients. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 46(11):2147\u20132153. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.011","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"2425_CR37","doi-asserted-by":"publisher","first-page":"9800","DOI":"10.1038\/srep09800","volume":"5","author":"J Zhang","year":"2015","unstructured":"Zhang J, Yao YH, Li BG, Yang Q, Zhang PY, Wang HT (2015) Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis. Sci Rep 5:9800. https:\/\/doi.org\/10.1038\/srep09800","journal-title":"Sci Rep"},{"key":"2425_CR38","unstructured":"37 Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor|Dermatology|JAMA Dermatology|JAMA Network. https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2731995. Accessed 13 July 2021"},{"issue":"12","key":"2425_CR39","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1002\/1097-0142(19800615)45:12<3012::aid-cncr2820451223>3.0.co;2-o","volume":"45","author":"CM Balch","year":"1980","unstructured":"Balch CM, Wilkerson JA, Murad TM, Soong SJ, Ingalls AL, Maddox WA (1980) The prognostic significance of ulceration of cutaneous melanoma. Cancer 45(12):3012\u20133017. https:\/\/doi.org\/10.1002\/1097-0142(19800615)45:12%3c3012::aid-cncr2820451223%3e3.0.co;2-o","journal-title":"Cancer"},{"issue":"6","key":"2425_CR40","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/SLA.0b013e31824c4b0b","volume":"255","author":"FEM Hout in\u2019t","year":"2012","unstructured":"Hout in\u2019t FEM, Haydu LE, Murali R, Bonenkamp JJ, Thompson JF, Scolyer RA (2012) Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma. Ann Surg 255(6):1165\u20131170. https:\/\/doi.org\/10.1097\/SLA.0b013e31824c4b0b","journal-title":"Ann Surg"},{"issue":"6","key":"2425_CR41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1309\/AJCPW56PHGLFTKZC","volume":"142","author":"ML B\u00f8nnelykke-Behrndtz","year":"2014","unstructured":"B\u00f8nnelykke-Behrndtz ML, Schmidt H, Christensen IJ et al (2014) Prognostic stratification of ulcerated melanoma: not only the extent matters. Am J Clin Pathol 142(6):845\u2013856. https:\/\/doi.org\/10.1309\/AJCPW56PHGLFTKZC","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"2425_CR42","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1002\/1097-0142(19931115)72:10<3091::aid-cncr2820721034>3.0.co;2-v","volume":"72","author":"MN Sirott","year":"1993","unstructured":"Sirott MN, Bajorin DF, Wong GY et al (1993) Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer 72(10):3091\u20133098. https:\/\/doi.org\/10.1002\/1097-0142(19931115)72:10%3c3091::aid-cncr2820721034%3e3.0.co;2-v","journal-title":"Cancer"},{"key":"2425_CR43","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/609323","author":"C Nieder","year":"2012","unstructured":"Nieder C, Marienhagen K, Dalhaug A, Norum J (2012) Towards improved prognostic scores predicting survival in patients with brain metastases: a pilot study of serum lactate dehydrogenase levels. Sci World J. https:\/\/doi.org\/10.1100\/2012\/609323","journal-title":"Sci World J"},{"issue":"3","key":"2425_CR44","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/bjc.2012.306","volume":"107","author":"B Weide","year":"2012","unstructured":"Weide B, Els\u00e4sser M, B\u00fcttner P et al (2012) Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis. Br J Cancer 107(3):422\u2013428. https:\/\/doi.org\/10.1038\/bjc.2012.306","journal-title":"Br J Cancer"},{"issue":"12","key":"2425_CR45","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1245\/s10434-013-3100-9","volume":"20","author":"CM Balch","year":"2013","unstructured":"Balch CM, jaw SS, Gershenwald JE et al (2013) Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol 20(12):3961\u20133968. https:\/\/doi.org\/10.1245\/s10434-013-3100-9","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2425_CR46","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12885-016-2438-3","volume":"16","author":"W Shen","year":"2016","unstructured":"Shen W, Sakamoto N, Yang L (2016) Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis. BMC Cancer 16(1):413. https:\/\/doi.org\/10.1186\/s12885-016-2438-3","journal-title":"BMC Cancer"},{"issue":"1","key":"2425_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.6001\/actamedica.v24i1.3460","volume":"24","author":"A Lideikait\u0117","year":"2017","unstructured":"Lideikait\u0117 A, Moz\u016braitien\u0117 J, Letautien\u0117 S (2017) Analysis of prognostic factors for melanoma patients. Acta Med Litu 24(1):25\u201334. https:\/\/doi.org\/10.6001\/actamedica.v24i1.3460","journal-title":"Acta Med Litu"},{"issue":"3","key":"2425_CR48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1245\/ASO.2004.04.015","volume":"11","author":"C Chao","year":"2004","unstructured":"Chao C, Martin RCG, Ross MI et al (2004) Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 11(3):259\u2013264. https:\/\/doi.org\/10.1245\/ASO.2004.04.015","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"2425_CR49","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/cncr.23359","volume":"112","author":"K Lasithiotakis","year":"2008","unstructured":"Lasithiotakis K, Leiter U, Meier F et al (2008) Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer 112(8):1795\u20131804. https:\/\/doi.org\/10.1002\/cncr.23359","journal-title":"Cancer"},{"issue":"1","key":"2425_CR50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12967-016-1026-2","volume":"14","author":"SA Weiss","year":"2016","unstructured":"Weiss SA, Han J, Darvishian F et al (2016) Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts. J Transl Med 14(1):299. https:\/\/doi.org\/10.1186\/s12967-016-1026-2","journal-title":"J Transl Med"},{"issue":"10","key":"2425_CR51","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/cam4.1152","volume":"6","author":"EAL Enninga","year":"2017","unstructured":"Enninga EAL, Moser JC, Weaver AL et al (2017) Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992\u20132011. Cancer Med 6(10):2203\u20132212. https:\/\/doi.org\/10.1002\/cam4.1152","journal-title":"Cancer Med"},{"issue":"6","key":"2425_CR52","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jaad.2008.08.007","volume":"59","author":"M Cockburn","year":"2008","unstructured":"Cockburn M, Swetter SM, Peng D, Keegan THM, Deapen D, Clarke CA (2008) Melanoma underreporting: why does it happen, how big is the problem, and how do we fix it? J Am Acad Dermatol 59(6):1081\u20131085. https:\/\/doi.org\/10.1016\/j.jaad.2008.08.007","journal-title":"J Am Acad Dermatol"},{"issue":"15","key":"2425_CR53","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006258","volume":"96","author":"K Mahendraraj","year":"2017","unstructured":"Mahendraraj K, Sidhu K, Lau CSM, McRoy GJ, Chamberlain RS, Smith FO (2017) Malignant melanoma in African-Americans. Medicine (Baltimore) 96(15):e6258. https:\/\/doi.org\/10.1097\/MD.0000000000006258","journal-title":"Medicine (Baltimore)"},{"key":"2425_CR54","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2147\/CCID.S311694","volume":"14","author":"J Brady","year":"2021","unstructured":"Brady J, Kashlan R, Ruterbusch J, Farshchian M, Moossavi M (2021) Racial disparities in patients with melanoma: a multivariate survival analysis. Clin Cosmet Investig Dermatol 14:547\u2013550. https:\/\/doi.org\/10.2147\/CCID.S311694","journal-title":"Clin Cosmet Investig Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02425-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02425-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02425-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T11:04:27Z","timestamp":1681124667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02425-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2425"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02425-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AD, SC, CY, VS, RS, BP, and RS all declare they have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}